How Much Weight Should I Lose on Semaglutide Per Week?

Last reviewed: June 7, 2026

Last updated: June 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by slowing stomach emptying and reducing hunger signals in the brain, leading to an average weight loss of 15–22% of body weight over 68 weeks in clinical trials. However, weekly weight loss is not linear—understanding what realistic progress looks like helps you stay motivated and make informed decisions about your treatment.

Realistic Weekly Weight Loss Expectations on Semaglutide

During the first 4–8 weeks of semaglutide therapy, many patients experience rapid initial weight loss of 2–4 pounds per week. This early phase often reflects loss of water weight and the immediate appetite-suppressing effects as your body adjusts to the medication. After this initial period, the rate typically stabilizes to 0.5–2 pounds per week, depending on your starting weight, calorie intake, and physical activity level.

Heavier patients often see faster absolute weight loss in the early weeks, while those with less weight to lose may progress more gradually. This variation is completely normal and does not indicate treatment failure. Consistency matters more than speed—sustainable weight loss of 1–1.5 pounds weekly is considered optimal for long-term metabolic health and muscle preservation.

PlexusDx compounded semaglutide injection begins at a low dose and increases gradually over 12 weeks, which helps your body adapt and minimizes side effects while allowing steady weight reduction. Your dose may need to go up. Your price won't—PlexusDx maintains flat monthly pricing regardless of dose adjustments, starting at $149 per month.

How Dose Escalation Affects Your Weekly Weight Loss Timeline

Semaglutide dosing follows a structured escalation protocol: you start at 0.25 mg weekly and increase every four weeks (0.5 mg, 1.0 mg, 1.7 mg, and up to 2.4 mg) until reaching your maintenance dose or target weight loss. Weight loss acceleration often coincides with dose increases, as higher concentrations strengthen the appetite-suppressing and metabolic effects.

Some patients experience a weight loss plateau when staying at the same dose for several weeks. This is a sign that your body has adapted and may indicate readiness for the next dose level. PlexusDx works with you to monitor progress and adjust timing based on your individual response—not all bodies follow the same calendar.

Weeks 1–4 typically show 4–8 pounds of loss; weeks 5–8 may bring 3–6 additional pounds; and by weeks 9–12, the rate often settles into 2–4 pounds weekly as you stabilize. After reaching your target dose, expect 0.5–2 pounds per week as a sustainable long-term rate.

Factors That Influence Your Individual Weight Loss Rate

Your baseline metabolic rate, age, sex, and muscle mass all play significant roles in how quickly semaglutide works. Younger patients and those with more muscle tissue often lose weight faster because muscle burns more calories at rest. Conversely, older adults or those on metabolic-slowing medications may see a slower but equally meaningful rate of change.

Genetic variations in GLP-1 receptor sensitivity and peptide metabolism pathways influence how your body responds to semaglutide. PlexusDx offers the Precision Peptide Genetic Test (a $99 add-on after your first month) to identify genetic markers like GLP1R rs6923761 and MC4R rs17782313 that predict your peptide-pathway responsiveness. This insight helps you understand whether you are a fast responder or steady progressor, setting realistic expectations from day one.

Diet quality, sleep duration, stress levels, and exercise intensity directly impact weekly weight loss. Patients who maintain a protein-rich diet and consistent strength training often lose fat preferentially while preserving lean muscle, resulting in more favorable body composition changes even if the scale moves slightly slower.

When to Expect a Plateau and How to Move Forward

Weight loss plateaus are normal and typically occur after 8–12 weeks of treatment as your body adapts to the medication and new calorie intake. A plateau does not mean semaglutide has stopped working—it means your body has reached equilibrium at a lower weight. Many patients plateau for 1–4 weeks before resuming steady loss with a dose increase or lifestyle adjustment.

If you reach a 2–3 week plateau without recent dose adjustment, this may signal readiness to advance to the next dose level. Some patients benefit from dietary tweaks: increasing water intake, evaluating hidden calories, or adding resistance training to stimulate new fat loss. PlexusDx providers can review your progress and recommend personalized adjustments to keep momentum moving without unrealistic expectations.

It's important to remember that the goal is sustainable, long-term weight management—not continuous rapid loss. Realistic weekly targets of 1–2 pounds place you on track for 52–100 pounds lost over a year, a transformative and medically healthy outcome that most people can maintain.

How PlexusDx Compounded Semaglutide Supports Consistent Progress

PlexusDx semaglutide injection comes from licensed 503A compounding pharmacies and is customized to your body's needs through thoughtful dose timing and escalation. Because PlexusDx pricing is flat—starting at $149 per month regardless of dose—cost concerns never prevent you from advancing when your provider recommends it. This removes a common barrier to optimal therapy.

PlexusDx serves all 50 states with no insurance requirement and no membership fee, making semaglutide accessible whether you have coverage or not. Medications are HSA and FSA eligible, further reducing out-of-pocket costs for many patients. Combined with the Precision Peptide Genetic Test, PlexusDx offers a truly personalized approach: genetic insights into your peptide metabolism inform realistic expectations and optimized dosing strategies.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight should I lose in my first month on semaglutide?

Most patients lose 4–8 pounds in the first month, primarily during weeks 1–4 when starting at 0.25 mg. This includes some water weight and represents the powerful appetite-suppressing effects as your body adapts. Month two often brings another 3–6 pounds as the dose increases to 0.5 mg.

Is 1 pound per week considered good progress on semaglutide?

Yes, absolutely. One pound per week is sustainable, safe, and places you on track for 50+ pounds lost annually. Clinical trials show this rate preserves muscle mass and allows your metabolism and lifestyle habits to adjust gradually, leading to better long-term weight maintenance.

Why do some people lose weight faster than others on semaglutide?

Starting weight, genetic variations in GLP-1 receptor function, age, muscle mass, and diet quality all influence speed. PlexusDx Precision Peptide Genetic Test identifies key variants like GLP1R rs6923761 and MC4R rs17782313 that predict your responsiveness, helping set realistic individual expectations.

What does PlexusDx semaglutide cost, and does pricing change with dose increases?

PlexusDx compounded semaglutide injection starts at $149 per month and remains flat across all dose levels—your dose may go up, but your price won't. No insurance is required, and treatment is HSA/FSA eligible and available in all 50 states.

Can genetic testing predict how much weight I'll lose on semaglutide?

PlexusDx Precision Peptide Genetic Test ($99 add-on after month one) analyzes 14 metabolic pathways and 49 peptides, including GLP-1 and GLP-2 receptor sensitivity markers. While genetics don't determine total loss, they reveal whether you're a fast or steady responder, helping align expectations with your biology.

Is it normal to have no weight loss one week but larger loss the next week?

Yes, weekly fluctuations are completely normal due to water retention, hormonal cycles, and how frequently you weigh yourself. Most patients see consistent downward trends over 2–4 week periods rather than every single week. Focus on monthly progress rather than daily or weekly spikes and dips.

Related Reading

• Semaglutide For Weight Loss 2
• Mounjaro Weight Loss By Week
• Semaglutide Tablets For Weight Loss
• Semaglutide Pills For Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.